-
AERI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Aerie Pharmaceuticals (AERI)
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 54.09 mm | 54.09 mm | 54.09 mm | 54.09 mm | 54.09 mm | 54.09 mm |
Cash burn (monthly) | (no burn) | 646.17 k | 8.91 mm | 2.46 mm | 3.80 mm | (no burn) |
Cash used (since last report) | n/a | 17.32 mm | 238.78 mm | 65.90 mm | 101.84 mm | n/a |
Cash remaining | n/a | 36.78 mm | -184.68 mm | -11.81 mm | -47.75 mm | n/a |
Runway (months of cash) | n/a | 56.9 | -20.7 | -4.8 | -12.6 | n/a |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 37.77 mm |
Total shares | 5.05 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Flynn James E | 4.70 mm | $32.96 mm |
Foresite Capital Fund II | 356.49 k | $4.81 mm |